Bausch & Lomb eye laser steps closer to market:
This article was originally published in Clinica
Executive Summary
Bausch & Lomb (B&L) is close to releasing its customisable laser vision correction system, Zyoptix, in the US following receipt of an approvable letter from the FDA. The letter signifies that the firm has largely fulfilled the agency's requirements for premarket approval, but asks for certain labelling changes. B&L says it expects final approval in the third quarter of 2003. Shares in rival US firm Visx dipped slightly following the B&L news. Visx sells an FDA-approved customisable laser system called CustomVue.